ConTIPI (PRIVATE.CONTIPI)

Overall impact
B (64)

Commentary

ConTIPI is a strong overall performer. With a 'B' rating of 64.4 for overall impact (72nd percentile compared to all companies), ConTIPI ranks 110th out of 194 industry peers, behind Restoration Robotics, Corindus Vascular Robotics, Modular Medical and 106 others, and ahead of Medtronic, Axonics Modulation Technologies, Star Equity Holdings and 81 others. On top material causes for ConTIPI's industry (Health Care Equipment & Supplies), ConTIPI performs well in Disease Eradication (96.0 score), Child and Maternal Health (94.0), Child and Maternal Health (95.2) and 21 other causes where it received an 'A' score and performs poorly in Decent, Safe Work Opportunities (18.2 score), Disaster Readiness and Effective Aid (33.1), Disaster Readiness and Effective Aid (33.1) and 21 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.CONTIPI
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2002
Employees
7
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Israel
Share classes
PRIVATE.CONTIPI
More info
Description
Provider of nonsurgical and disposable vaginal solutions for women intended for various pelvic floor dysfunctions. The company offers devices such as stress urinary incontinence and pelvic organ prolapse, enabling women to be safe and tension-free all day long.
Material causes
Ethos considers the following causes material for ConTIPI, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.